A phase II trial of cisplatin and irinotecan alternating with doxorubicin, cyclophosphamide and etoposide in previously untreated patients with extensive-disease small-cell lung cancer

被引：0
|
作者：
Masahiro Tabata
Katsuyuki Kiura
Niro Okimoto
Yoshihiko Segawa
Tetsu Shinkai
Toshiro Yonei
Shoichi Kuyama
Shingo Harita
Katsuyuki Hotta
Hiroshi Ueoka
Mitsune Tanimoto
机构：
[1] Okayama University Medical School,Department of Medicine II
[2] Kawasaki Hospital,Department of Medicine
[3] National Hospital Organization Shikoku Cancer Center,Department of Medicine
[4] National Hospital Organization Okayama Medical Center,Department of Respiratory Medicine
[5] Chugoku Central Hospital,Department of Medicine
[6] National Hospital Organization National Sanyo Hospital,Department of Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2007年 / 60卷
关键词：
Small-cell lung cancer; Alternating chemotherapy; Irinotecan;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1 / 6
页数：5
相关论文
共 50 条
  • [1] A phase II trial of cisplatin and irinotecan alternating with doxorubicin, cyclophosphamide and etoposide in previously untreated patients with extensive-disease small-cell lung cancer
    Tabata, Masahiro
    Kiura, Katsuyuki
    Okimoto, Niro
    Segawa, Yoshihiko
    Shinkai, Tetsu
    Yonei, Toshiro
    Kuyama, Shoichi
    Harita, Shingo
    Hotta, Katsuyuki
    Ueoka, Hiroshi
    Tanimoto, Mitsune
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (01) : 1 - 6
  • [2] Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer
    Hanna, N
    Bunn, PA
    Langer, C
    Einhorn, L
    Guthrie, T
    Beck, T
    Ansar, R
    Ellis, P
    Byrne, M
    Morrison, M
    Hariharan, S
    Wang, B
    Sandler, A
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (13) : 2038 - 2043
  • [3] Irinotecan and etoposide for previously untreated extensive-disease small cell lung cancer: A phase II trial of West Japan Thoracic Oncology Group
    Kudoh, S
    Nakamura, S
    Nakano, T
    Komuta, K
    Isobe, T
    Katakami, N
    Fukuda, Y
    Takada, Y
    Takada, M
    Fukuoka, M
    Ariyoshi, Y
    LUNG CANCER, 2005, 49 (02) : 263 - 269
  • [4] The phase II trial of fractionated irinotecan plus carboplatin for previously untreated extensive-disease small cell lung cancer
    Choi, Hye Jin
    Kim, Joo Hang
    Sohn, Joo Hyuk
    Kim, Se Kyu
    Lee, Chang Geol
    Cho, Jae Yong
    Kim, Yong Tae
    ANNALS OF ONCOLOGY, 2006, 17 : 225 - 225
  • [5] A phase II trial of fractionated irinotecan plus carboplatin for previously untreated extensive-disease small cell lung cancer
    Sohn, Joo Hyuk
    Choi, Hye Jin
    Chang, Joon
    Kim, Se Kyu
    Lee, Chang Geal
    Chung, Kyung Young
    Kim, Dae Joon
    Cho, Byoung Chul
    Shin, Sang Joon
    Moon, Yong Wha
    Kim, Joo-Hang
    LUNG CANCER, 2006, 54 (03) : 365 - 370
  • [6] Randomised phase II trial of irinotecan plus cisplatin vs irinotecan, cisplatin plus etoposide repeated every 3 weeks in patients with extensive-disease small-cell lung cancer
    I Sekine
    H Nokihara
    K Takeda
    Y Nishiwaki
    K Nakagawa
    H Isobe
    K Mori
    K Matsui
    N Saijo
    T Tamura
    British Journal of Cancer, 2008, 98 : 693 - 696
  • [7] Randomised phase II trial of irinotecan plus cisplatin vs irinotecan, cisplatin plus etoposide repeated every 3 weeks in patients with extensive-disease small-cell lung cancer
    Sekine, I.
    Nokihara, H.
    Takeda, K.
    Nishiwaki, Y.
    Nakagawa, K.
    Isobe, H.
    Mori, K.
    Matsui, K.
    Saijo, N.
    Tamura, T.
    BRITISH JOURNAL OF CANCER, 2008, 98 (04) : 693 - 696
  • [8] Randomized, phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated, extensive-stage, small-cell lung cancer (SCLC)
    Langer, C
    Hanna, N
    Einhorn, L
    Sandler, A
    Ansari, R
    Ellis, R
    Byrne, M
    Green, M
    Morrison, M
    Bunn, P
    LUNG CANCER, 2005, 49 : S53 - S54
  • [9] CISPLATIN AND ETOPOSIDE ALTERNATING WITH VINCRISTINE, DOXORUBICIN AND CYCLOPHOSPHAMIDE IN PATIENTS WITH SMALL-CELL LUNG-CANCER
    LITTLEWOOD, TJ
    SMITH, AP
    ANDERSON, G
    CHAPPELL, AG
    JAMES, KW
    EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 1985, 67 (04): : 294 - 300
  • [10] Phase II study of irinotecan combined with cisplatin in patients with previously untreated small-cell lung cancer
    Kudoh, S
    Fujiwara, Y
    Takada, Y
    Yamamoto, H
    Kinoshita, A
    Ariyoshi, Y
    Furuse, K
    Fukuoka, M
    Takada, M
    Ikegami, H
    Nishikawa, H
    Nakajima, S
    Hoso, T
    Higashino, K
    Takahara, J
    Kamei, M
    Yamakido, M
    Ryu, S
    Hara, N
    Fukuda, M
    Kinuwaki, E
    Tanaka, F
    Senba, H
    Araki, J
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (03) : 1068 - 1074
12345